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A mouse model of short-term dietary
changes, which happen when humans
are traveling to places with different
culinary traditions, reveals how a single
food ingredient interacts with a functional
microbiota trait to regulate host
physiology.
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To understand how different diets, the consumers’
gut microbiota, and the enteric nervous system
(ENS) interact to regulate gut motility, we developed
a gnotobiotic mouse model that mimics short-term
dietary changes that happen when humans are trav-
eling to places with different culinary traditions.
Studying animals transplanted with the microbiota
from humans representing diverse culinary traditions
and fed a sequence of diets representing those of all
donors, we found that correlations between bacterial
species abundances and transit times are diet
dependent. However, the levels of unconjugated
bile acids—generated by bacterial bile salt hydro-
lases (BSH)—correlated with faster transit, including
during consumption of a Bangladeshi diet. Mice
harboring a consortium of sequenced cultured bac-
terial strains from the Bangladeshi donor’s micro-
biota and fed a Bangladeshi diet revealed that the
commonly used cholekinetic spice, turmeric, affects
gut motility through amechanism that reflects bacte-
rial BSH activity and Ret signaling in the ENS. These
results demonstrate how a single food ingredient in-
teracts with a functional microbiota trait to regulate
host physiology.INTRODUCTION
Gut motility, a key physiologic parameter governing digestion
and absorption of nutrients, is affected by diet (Cummings
et al., 1976, 1978), gut microbes (Husebye et al., 1994, 2001;
Wichmann et al., 2013), the enteric nervous system (ENS) (Edery
et al., 1994; Romeo et al., 1994), and host genetics (Levy et al.,
2000; Whorwell et al., 1986). At present, we lack detailed under-
standing of the complex and dynamic interrelationships between
these factors, particularly in the global context of diverse culturaltraditions concerning foods, their methods of preparation, and
the varied human gut microbiota that have evolved under these
dietary conditions. Intestinal transit times measured in >1,000
healthy individuals representing diverse populations worldwide
varied within and between groups, likely reflecting a combination
of these factors (Burkitt et al., 1972). The advent of culture-inde-
pendent methods for characterizing the structure and expressed
functions of a gut microbiota creates an opportunity to identify
new approaches for understanding gut motility and optimizing
the nutritional benefits derived from different dietary practices.
In the present study, we began by modeling short-term diet
changes associated with global human travel in gnotobiotic
mice colonized with gut microbiota from healthy human donors
from around the world. We hypothesized that with an interna-
tional focus, we could conduct a screen of food types and
microbiota for potential mediators of motility common to diverse
diets and gut communities. Without making any assumptions
regarding the healthiness of faster or slowermotility, our strategy
was to identify diets and microbiota whose interactions result in
highly contrasting transit times in order to subsequently home
in on specific dietary ingredients and microbiota-encoded meta-
bolic capacities that affect motility. We reasoned that by gener-
ating clonally arrayed collections of bacterial strains cultured
from donor microbiota that transmitted disparate motility pheno-
types in different dietary settings, we could deliberately manipu-
late which members of the collection were used for colonization
ofmice basedon specificmetabolic attributes that could be iden-
tified from their genomes and confirmed by direct biochemical
assays in vitro. Colonizationwith different subsets of the commu-
nity could then be performed in the context of concurrently
manipulated diets, either in wild-type animals or in those with
deliberately manipulated genetic features known to affect ENS
function. Our immediate goal for this type of preclinical modeling
was to decipher the mechanisms by which diet-by-microbiota
interactions can regulate gut motility. Our long-term goal was to
implement an approach that could, in principle, be generalized
to dissect the effects of interactions between (1) ingredients rep-
resented in established as well as emerging dietary traditions/
trends, (2) members of consumers’ gut microbiota, and (3) gut
motility and potentially other aspects of human physiology.Cell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc. 95
Figure 1. Compositions of Diets Used in the
Six-Phase Travel Experiment
In the foreground, word clouds convey the specific
ingredients used; font sizes depict the weight-
based proportional representations of ingredients
within each diet. Pie charts in the background
represent the macromolecular compositions. See
also Table S1.RESULTS
Modeling Diet and Motility Changes Associated with
Global Human Travel in Gnotobiotic Mice
In an initial ‘‘travel’’ experiment, intact uncultured fecalmicrobiota
samples obtained from six healthy adults representing different
geographic locations and cultural/culinary traditions were trans-
planted into adult germ-free C57BL/6 male mice (n = 6 recipient
mice/donormicrobiota).Microbiotadonors included (1) three res-
idents of the USA (a twin pair stably discordant for obesity with
both co-twins consuming an American diet without self-imposed
dietary restrictions (USAunrestricted) (Ridaura et al., 2013) plus
another lean individual who had consumed a protein- and fat-
richprimal diet for a number of years (USAprimal), (2) anAmerindian
living in a remote rural village in the Amazonas State of Venezuela
(Yatsunenko et al., 2012), (3) a Bangladeshi resident of an urban
slum (Subramanian et al., 2014), and (4) a Malawian from a rural
village in the southern part of the country (Yatsunenko et al.,
2012) (see Table S1A for a description of donor characteristics
and Table S1B for analysis of microbiota transplantation effi-
ciency). The six groups of transplant recipients were fed a
sequence of six sterilized diets formulated to represent those
consumed by the microbiota donors (Figure 1; Tables S1C and
S1D), in essencesimulating the varyingdietary experiencesof hu-
mans and their microbiota during travel. In each case, the initial
and final diets in the sequence represented the native or home
diet of the donor, in order to characterize the longer-term effects
of dietary exposures during travel and the degree to which transit
times recover. In between, travel diets were given in the same
sequence, in an order chosen randomly but executed uniformly
for all mice, as permitted by the type of home diet (Figure 2A).
The starting and ending home diets were given for 14 and
8 days, respectively, while each travel diet was administered for
8 days. Intestinal transit times were measured at the end of
each diet phase by gavaging mice with non-absorbable red
carmine dye and recording the time from gavage to first appear-
ance of the dye in their feces (Kashyap et al., 2013; Li et al., 2011;
Yano et al., 2015) (Figure 2B; Table S2A). Carmine dye does not
perturb the structure of the gut bacterial community; 16S rRNA
analysis of fecal samples, collected before and after carmine
administration from 9-week-old gnotobiotic mice colonized with
a fecal microbiota from a conventionally raised C57BL/6 donor,96 Cell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc.showed no significant effect of the dye
as judged by weighted UniFrac distances
(p > 0.05, two-tailed Student’s t test).
Moreover, fecal samples collected on the
days of transit time measurements were
taken prior to carmine administration.Aggregating data from all animals at all time points of this
six-phase travel experiment revealed a normal distribution of
transit times (Figure 2C). The average within-mouse variance
throughout the experiment was 27.7 min, while the average be-
tween-mouse variance at a given time point was 29.3 min.
Repeated-measures ANOVA in which transit time was the
dependent variable demonstrated that diet (p = 5.6 3 105),
the donor microbiota (p = 2.3 3 103), and the interaction of
diet and microbiota (p = 2.6 3 103) were all significant factors
(Table S3A). The most contrasted diet-by-microbiota effects on
transit times were documented in mice colonized with the Ban-
gladeshi compared to the USAunrestricted microbiota when they
consumed Bangladeshi and primal diets (Figure 2D). Specif-
ically, mice colonized with the USAunrestricted microbiota had
significantly faster motility (i.e., shorter transit times) when
consuming the Bangladeshi diet compared to primal diet (p <
0.002, two-tailed Student’s t test); the opposite was observed
in mice colonized with a Bangladeshi microbiota (p < 0.006,
two-tailed Student’s t test). We tested the robustness of these
most contrasted motility phenotypes by colonizing animals
with fecal microbiota obtained from three healthy Bangladeshi
adults (including the donor tested in the first experiment) and
three healthy USAunrestricted adults (a repeat of the obese co-
twin in the discordant pair, plus a new obese and a new lean
donor; see Table S1A for donor characteristics). Recipients
(n = 5 mice/donor microbiota) were subjected to three diet
phases beginning and ending with a ‘‘local’’ diet (i.e., the primal
diet for mice colonized with a USAunrestricted microbiota or the
Bangladeshi diet for mice colonized with a Bangladeshi micro-
biota) and including an interval ‘‘non-native’’ diet (Figure S1A).
The results of this three-phase travel experiment confirmed
that significantly contrasted transit times were imparted by the
interactions of these diets and microbiota (p < 2.6 3 105,
F = 19.8, analysis of covariance [ANCOVA]), although the effect
size and statistical significance of differences in transit time var-
ied by the individual microbiota donor (Figure S1B; Table S2B).
Correlations between the Relative Abundances of Gut
Bacterial Strains and Transit Times Are Diet Dependent
To identify relationships between specific bacterial taxa, diet,
and transit time phenotypes, we sequenced PCR amplicons
generated from the V4 region of bacterial 16S rRNA genes
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Figure 2. Diet and Microbiota Significantly Impact Intestinal Transit Times
(A) Schematic of the six-phase travel experiment. Groups of adult germ-free C57BL/6 mice were colonized with fecal microbiota from six healthy donors and fed
diets representative of those consumed by all donors in the sequence shown in (B).
(B) The central squares of this heatmap represent means of transit times for each diet-microbiota combination as measured by a carmine red dye assay; the
frames of the squares represent SEM (n = 6 mice/donor microbiota). Microbiota are represented along rows and diet phases along columns. Each group of mice
consumed human diets in the order shown from left to right; home diets were always consumed during the initial and final diet phases but skipped in the
intervening travel diet progression (primal diet ➡ unrestricted American diet ➡ Bangladeshi diet ➡ Malawian diet ➡ Amerindian diet).
(C) Histogram showing distribution of all transit times recorded throughout the six-phase travel experiment.
(D) The most contrasted diet-by-microbiota effects on transit times were observed in mice colonized with a Bangladeshi or USAunrestricted microbiota and fed
Bangladeshi versus primal diets. Results for USAunrestricted (lean) and USAunrestricted (obese) were aggregated and are represented together as USAunrestricted.
Results from the ‘‘home’’ and ‘‘return home’’ phases for mice colonized with a Bangladeshi microbiota and fed a Bangladeshi diet were also aggregated.
Statistical significance was determined using a two-tailed Student’s t test; *p < 0.05. Within each box, the horizontal line denotes the mean value of the transit
times. The lower and upper boundaries of each box represent the 25th and 75th percentiles, respectively, while whiskers represent 1.5 times the interquartile
range.
See also Figures 1, 3, S1, and S2 and Tables S1, S2, S3, S4, and S5.present in fecal microbiota collected throughout the course of
the six-phase as well as three-phase travel experiments (984
fecal samples; 22,470 ± 630 reads per sample [mean ± SEM];
Table S4). 16S rRNA reads were grouped into operational taxo-
nomic units based on whether they shared R97% nucleotide
sequence identity (97%ID OTUs). Principal coordinates analysis
(PCoA) based on unweighted UniFrac, a phylogeneticmetric that
computes similarity between any two microbiota based on the
degree to which their component OTUs share branch length on
a bacterial tree (Lozupone and Knight, 2005), indicated that com-
munity assembly was rapid and highly reproducible within a
given group of mice that received the same donor microbiota
in both the six-phase and three-phase travel experiments (Fig-
ures S2A and S2C).
The microbiota donor was the predominant factor explaining
variance in unweighted UniFrac distances between samples
from the different experimental groups (p < 0.001 within-group
ascompared tobetween-groupsimilarity, permutationalmultivar-
iate analysis of variance using distance matrices [PERMANOVA];
Figures S2B and S2D). Nonetheless, diet had consistent effects
across different treatment groups and phenotypes: 87 diet-
discriminatory 97%IDOTUs that were robust to donormicrobiotaand motility phenotypes were identified by applying a machine
learning algorithm (Random Forests) to the 16S rRNA dataset
generated from all fecal microbiota samples collected from all
mouse recipients of all human donor microbiota throughout
the six-phase travel experiment (Figure 3; Table S5). We elected
to apply a decision-tree-based algorithm for feature selection
(i.e., in this case, the most diet-discriminatory OTUs) so that
we would not have to make any distributional assumptions
regarding our dataset of proportional OTU abundances. The
Random Forests-derived model predicted which diet was being
consumed in the subsequent three-phase travel experiment
with a mean accuracy of 83% ± 0.02% (range 79%–86%;
10,000 replications), significantly better than the null distribution
(p < 2.2 3 1016). These 87 diet-discriminatory OTUs were
not significantly correlatedwith transit times across alldiet-micro-
biota combinations in either experiment. In an analysis of all 416
97%ID OTUs with relative abundances above the limit of detec-
tion (0.01%) in mouse fecal samples collected throughout both
travel experiments, just a single OTU, Parabacteroides gordonii
(OTU ID240),wassignificantly correlated, afterBonferroni correc-
tion for multiple comparisons, with transit times across the highly
contrasteddiet-microbiotacombinations (rho=0.3,p=0.02). ThisCell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc. 97
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Figure 3. Diet-Discriminatory OTUs Are
Robust to Different Donor Microbiota and
Motility Phenotypes
(A) Out-of-bag (OOB) estimated error rates in a
Random Forests model for predicting diet, stratified
by donormicrobiota, as a function of numbers of diet-
discriminatory OTUs. For each microbiota, 40 OTUs
were sufficient to discriminate diet, yielding a total of
87 unique OTUs across six microbiota donors from
five cultural/dietary traditions in the six-phase travel
experiment.
(B) Evidence for the robustness of diet-discriminatory
OTUs to donor microbiota and motility phenotype.
Feature importance scores of 87 diet-discriminatory
OTUs in each diet-microbiota context are repre-
sented in this heatmap, which was generated
following unsupervised hierarchical clustering. A
sparse Random Forests model built using these diet-
discriminatory OTUs accurately predicted diet in the
three-phase travel experiment.
See also Table S5.
98 Cell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc.
organism has not been reported to be associated with altered in-
testinal motility in humans.
We identified 27 OTUs present in both the USAunrestricted and
Bangladeshi microbiota that had significant diet-dependent cor-
relations with transit times documented in the context of either
the Bangladeshi or primal diets, but not both (Table S3B). The
relationships of bacteria to transit times were strain specific:
two strains of Eubacterium desmolans (OTU IDs 170124
and 158946) had opposing relationships with transit times
within the setting of primal diet consumption. A single OTU,
E. desmolans (OTU ID 158946), was significantly correlated
with transit times in both diets, but remarkably, the correlations
were opposite in the Bangladeshi versus primal diet contexts
(p < 9.3 3 106, F = 9.6, ANCOVA testing interaction of
E. desmolans abundance with diet). In the unrestricted USA
diet context, yet another OTU in the USAunrestricted and Bangla-
deshi microbiota (Clostridiales, OTU ID 261590) was correlated
with transit times (rho = 0.57, p = 0.04). Hence, a next-genera-
tion probiotic strain designed to impact motility may require
simultaneous consumption of a specific diet or diet ingredient
to exert its effect.
Transit times at the ends of the initial and final home diets often
varied. This finding could not be ascribed to increasing age
(p = 0.7, F = 0.1, one-way ANOVA of transit time as a function
of age). Mathematically, if we consider two functions h(m) and
t(m), then h(m) need not necessarily equal h(t(h(m))). We postu-
lated that if these two functions represent the effects of
home (h) and travel (t) diets, respectively, on a microbiota m,
then the result of a home diet may depend on whether inter-
vening travel diets were consumed. Indeed, an analysis
comparing fecal microbiota at the ends of the initial and final
home phases in the six-phase travel experiment disclosed that
community structure, while largely similar, always exhibited
statistically significant changes (p < 0.05, paired two-tailed Stu-
dent’s t test after Bonferroni correction) in the proportional abun-
dances of one or more OTUs. For example, mice colonized with
fecal microbiota from both USAunrestricted individuals exhibited a
significant increase in the relative abundance of Bacteroides
ovatus between the first and last home diet periods, while mice
colonized with microbiota from the adult Bangladeshi donor ex-
hibited significantly increased abundances of an OTU classified
as Clostridiales, and a decrease in Ruminococcus obeum.
The imperfect recovery of transit time following diverse dietary
exposures during travel could reflect not only these structural
differences but also functional differences in the microbiota.
Therefore, we characterized metabolic features of the micro-
biota in the context of the most highly contrasted motility
phenotypes.
Microbially Deconjugated Bile Acid Metabolites Are
Correlated with Faster Gut Transit
To identify metabolic features that correlate with motility pheno-
types, we applied ultra-high-performance liquid chromatog-
raphymass spectrometry (UPLC-MS) to fecal samples collected
frommice in the three-phase travel experiment on the same days
when their transit times were measured (three USAunrestricted and
three Bangladeshi donor microbiota; five mice/donor micro-
biota; three fecal samples analyzed/mouse). We observed>2,500 unique m/z peaks that were present in more than one
mouse. Spearman’s rank correlations (without Bonferroni
correction) yielded 599 m/z peaks that were significantly corre-
lated with transit times, of which 67 (11%) were putatively iden-
tified as bile acid metabolites (Tables S6A and S6B). In mice, the
predominant primary bile acids are beta-muricholic acid and
cholic acid, while in humans they are chenodeoxycholic acid
and cholic acid (Haslewood, 1967). Prior to secretion from hepa-
tocytes into biliary canaliculi, bile acids are conjugated with
either taurine (predominant in mice; Falany et al., 1997) or glycine
(predominant in humans; Falany et al., 1994) to decrease passive
absorption by intestinal enterocytes. Bile acids have microbici-
dal activity; members of the gut microbiota neutralize these
effects by metabolizing host bile acids, beginning with deconju-
gation catalyzed by microbial bile salt hydrolases (BSHs) (Drasar
et al., 1966). Since bile acids are modified by the microbiota,
we considered whether differences in bile acid metabolite pro-
files could explain discordant microbiota-associated motility
phenotypes.
To gain insights into the relationships between OTUs and bile
acid metabolites as they pertain to transit times, we calculated
Spearman’s rank correlation coefficients between the propor-
tional abundances of 97%ID OTUs in fecal microbiota, the
peak intensities of fecal bile acids, and transit times in the
three-phase travel experiment (Figure 4; Table S6B). After Bon-
ferroni correction, we identified 118 OTUs with significant corre-
lations between their abundances and levels of one ormore fecal
bile acids; only one of these OTUs, Blautia (OTU ID 296977), also
had a significant correlation between its abundance and transit
times (slower transit) (Table S6B). A sparse linear model, built
after regressing transit times against all bile acid metabolite
levels then simplified by applying stepwise backward feature
selection, demonstrated that levels of just five bile acids (7-keto-
deoxycholic acid, muricholic acid, taurocholic acid, tauro-beta-
muricholic acid, and tauro-muricholic acid sulfate) accurately
predicted transit times in the three-phase travel experiment
(rho = 0.54, p = 1.83 107, Spearman’s rank correlation), outper-
forming a linear model built with an equivalent number of
randomly selected non-bile-acid metabolites (rho = 0.17,
p = 0.47, Spearman’s rank correlation; mean values over 1,000
replications) (Figure S1C; Table S6C). Of these five bile acids,
none was significantly associated with either diet. Only one bile
acid species, tauro-muricholic acid sulfate, was significantly
associated with the geographic origin of the microbiota donor;
it was found at significantly higher concentrations in fecal spec-
imens collected from mice colonized with subjects residing in
Bangladesh (Figure 4). Bile acids that were correlated with faster
transit times were unconjugated (7-ketodeoxycholic acid and
muricholic acid), whereas those that correlated with slower
transit times were conjugated (tauro-beta-muricholic acid, taur-
ocholic acid, and tauro-muricholic acid sulfate) (Figure 4; Table
S6B). Levels of multiple bile acids, including these five bile
acids, were significantly correlated withmultiple OTUs (Figure 4),
underscoring the complexity of microbial bile acid metabolism.
Turmeric Alters Gut Motility
Intestinal bile acid concentrations are largely dictated by dietary
components (e.g., peptides and fats) that trigger intestinalCell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc. 99
Figure 4. Significant Correlations between
Fecal Bile Acid Metabolite Concentrations
and the Relative Abundances of Bacterial
97%ID OTUs
Bile acid metabolite profiling and 16S rRNA analysis
was performed on fecal samples collected from mice
in the three-phase travel experiment (Figure S1).
Spearman rank correlations were calculated between
bile acid concentrations and relative abundances of
97%ID OTUs. Unsupervised hierarchical clustering
was applied. Significant associations (p < 0.05
calculated by two-tailed Student’s t test, with Bon-
ferroni correction) between microbiota/diet and bile
acids/OTUs are represented in the vertical and hori-
zontal side panels. Associations between bile acid
levels and transit times were calculated by linear
modeling with stepwise backward feature selection,
as detailed in the text and Supplemental Experimental
Procedures.
See also Figures S1 and Tables S4 and S6.
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signals (e.g., cholecystokinin), which, in turn, influence gall-
bladder contraction and release of bile into the lumen of the
proximal small intestine. To further characterize interactions be-
tween specific OTUs, bile acid metabolism, and diet, we exam-
ined the effects of turmeric on transit time. We selected turmeric,
a spice with cultural significance commonly used in Bangladeshi
cuisine, because it has a dose-dependent cholekinetic effect;
i.e., its active ingredient, curcumin, stimulates gallbladder
contraction and thus increases luminal bile acid levels. The effect
sizes of turmeric’s cholekinesis vary between reported studies,
possibly due to population-based differences (e.g., European
versus Asian subjects) or differences in how the spice was
administered (Marciani et al., 2013; Rasyid and Lelo, 1999;
Rasyid et al., 2002). In a study using serial hydrogen breath tests
to assess carbohydrate fermentation and small bowel transit
time, investigators observed that turmeric-containing Japa-
nese-style curry fed to Japanese individuals increased fermenta-
tion and shortened small bowel transit time compared to curry
prepared without turmeric (Shimouchi et al., 2009). Themicrobial
underpinnings of these observations in human subjects are
unknown, as metagenomic or metabolomic analyses of their
gut microbiota were not performed.
We initially defined the effect of turmeric in adult male C57BL/6
gnotobiotic mice colonized with a collection of anaerobic bacte-
rial strains cultured from the fecal microbiota of a healthy 2-year-
old Bangladeshi child (Table S7A). We generated this culture
collection from a child rather than an adult to avoid the potential
confounding effects of chronic antecedent turmeric exposure on
microbiota features. This child, like the three Bangladeshi adults
whose microbiota were tested in the earlier experiments, lived in
Mirpur, an urban sub-district of Dhaka. The sequenced, clonally
arrayed bacterial culture collection gave us the capacity to
perform follow-up experiments in which specific strains were
selected for colonization based on their capacity to metabolize
bile acids.
Following gavage of the entire culture collection, composed of
53 bacterial strains (Table S7A), mice were initially fed a Bangla-
deshi diet lacking turmeric for 10 days (diet phase 1), then the
same diet containing turmeric for 10 days (diet phase 2), and
finally the unsupplemented Bangladeshi diet again for 10 days
(diet phase 3). A control group was maintained under germ-
free conditions and subjected to the same sequence of diets
(n = 6 animals/group). To limit carryover of turmeric from the prior
diet, old bedding was replaced with fresh new bedding at the
start of each diet phase.
Colonization was highly reproducible between animals, with
community assembly completed within 3–5 days after gavage.
At the end of the first diet phase, 44 ± 1.2 (mean ± SEM) of the
53 input strains were detectable in fecal samples collected
from recipient animals, based on community profiling by shotgun
sequencing (COPRO-seq) of fecal DNA (see Experimental Pro-
cedures). Colonized mice had significantly faster transit times
at each diet phase compared to their germ-free counterparts
(p = 5.0 3 106, p < 4.7 3 107, and p < 1.7 3 105 for diet
phases 1, 2, and 3, respectively, two-tailed Student’s t test;
Table S2C). Consumption of turmeric was associated with a sig-
nificant slowing of motility (i.e., longer transit time) (Table S2C).
UPLC-MS of fecal samples collected from germ-free mice atthe end of each diet phase disclosed that ingestion of this chol-
ekinetic spice was associated with significantly increased levels
of taurohyodeoxycholic acid (p = 0.003, one-tailed Student’s
t test) and tauro-muricholic acid sulfate (p = 0.03, one-tailed Stu-
dent’s t test) compared to the period of unsupplemented diet
consumption (Table S6A). As expected, no unconjugated bile
acids were detected in the germ-free group during any of the
diet phases. We included a curcumin standard in order to quan-
tify fecal curcumin levels; however, curcumin was undetectable
in all samples.
To directly test the hypothesis that microbiota with different
capacities to deconjugate bile acids transmit distinct transit
time phenotypes, we first used a UPLC-MS-based in vitro assay
to screen all members of the clonally arrayed culture collection
for their BSH (EC 3.5.1.24) activities. The screen demonstrated
that OTUs representing a number of phylotypes had the ability
to deconjugate at least one of the two primary bile acids found
in mice (Table S7A). BLAST predictions, based on the presence
in a strain’s genome of homologs of known BSH genes (E-value
threshold cutoff %105) were correct in predicting in vitro BSH
enzymatic activity for 85% of the bacterial strains. Only ten
strains did not deconjugate either bile acid in vitro (six members
of the genus Enterococcus, three members of Eggerthella, and
one belonging to Enterobacteriaceae). The strains with BSH ac-
tivity were largely members of the genera Bifidobacterium and
Enterococcus. We then assembled two bacterial consortia,
each composed of seven strains representing the taxonomic di-
versity of the BSH-positive and BSH-negative subsets within the
culture collection: the ‘‘BSHhi’’ consortium contained four mem-
bers of Enterococcus and three members of Bifidobacterium,
and the ‘‘BSHlo’’ consortium had five members of Enterococcus,
one Eggerthella species, and one Enterobacteriaceae (see Table
S7B for a summary of KEGG-based annotations of the
sequenced genomes of these 14 strains). Members of the two
consortia had in vitro growth rates under anaerobic conditions
in rich medium that were not significantly different from one
another (p = 0.92, two-tailed Student’s t test).
Age-matchedadultmaleC57BL/6 gnotobioticmicewere colo-
nizedwith either the BSHhi or BSHlo consortium (assembled prior
to gavage by combining equal numbers of colony-forming units
of each component strain). A positive control group was colo-
nized with the entire culture collection. As before, mice in each
of these three groups (n = 5/group) were given the unsupple-
mented Bangladeshi diet for 3 days prior to gavage of the
cultured organisms. Following gavage, mice were maintained
on the unsupplemented Bangladeshi diet for 8 days, followed
by the turmeric-supplemented diet for 8 days, and then returned
to the starting Bangladeshi diet for another 8 days. The complete
culture collection produced a transit time that was significantly
faster than that measured with the BSHlo consortium in all three
diet phases (p < 0.002, one-tailed Student’s t test; Table S2D).
While mice harboring the BSHlo consortium had the same transit
time as the BSHhi consortium in the absence of turmeric, addition
of this spice to theBangladeshi diet produced significantly slower
transit times inBSHlo animals (p=0.02, one-tailedStudent’s t test
comparing phase 1 versus phase 2 transit times; Figure 5A) but
no significant effects in BSHhi mice (p = 0.7, one-tailed Student’s
t test). These findings indicate that a gut microbiota capable ofCell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc. 101
AC D
B
Figure 5. An Interaction Between Diet, Bile Acid Metabolism, and
Gut Motility Revealed by Colonizing Germ-free Mice with a BSHhi or
BSHlo Consortium and Feeding Them a Representative Bangladeshi
Diet with or without Turmeric
(A) Turmeric consumption resulted in significantly slower motility in mice
colonized with the BSHlo, but not the BSHhi consortium.
(B) While consuming the turmeric-supplemented Bangladeshi diet, BSHhi mice
had transit times comparable to mice colonized with the complete 53-strain
culture collection (‘‘CC’’) and faster motility (i.e., shorter transit times) than
BSHlo mice (n = 5 animals/microbiota). In this comparison, data for BSHlo and
BSHhi are the same as in (A).
(C) Turmeric consumption is associated with a significant increase in total fecal
unconjugated bile acid concentrations in gnotobiotic wild-typemice colonized
with the BSHhi consortium, but not the BSHlo consortium.
(D) Transit times measured for two groups of gnotobiotic mice colonized with
BSHlo consortium and fed the unsupplemented or turmeric-containing Ban-
gladeshi diet. Measurements occurred at the end of the 10-day monotonous
diet experiment.
Statistical significance was determined using a one-tailed Student’s t test.
*p < 0.05. In (A), (B), and (D), transit times are represented by mean values ±
SEM. In (C), the horizontal line within each box denotes the mean value of the
measured transit times. The lower and upper boundaries of each box repre-
sent the 25th and 75th percentiles, respectively, while whiskers represent 1.5
times the interquartile range. See also Tables S4, S6, S7, and S8.deconjugating bile acids could modify the response to turmeric,
which through its cholekinetic effectsdelivers increasedamounts
of conjugated bile acids to the proximal intestine.
Mice colonized with the BSHlo consortium had significantly
slower motility than BSHhi animals only in the setting of turmeric
(p < 0.03, one-tailed Student’s t test; Figure 5B). UPLC-MS
confirmed that BSHhi mice had significantly higher total concen-
trations of fecal unconjugated bile acids (p = 0.01, one-tailed
Student’s t test) and significantly lower total concentrations of102 Cell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc.conjugated bile acids (p = 0.02, one-tailed Student’s t test)
compared to mice colonized with the BSHlo consortium (Fig-
ure 5C; Table S6A). Total concentrations of the two unconju-
gated primary bile acids (cholic acid and beta-muricholic acid)
were significantly negatively correlated with transit times
(rho = 0.76, p = 3.6 3 109, Spearman’s rank correlation).
COPRO-Seq revealed that turmeric had no statistically signifi-
cant effects on the representation of any strain in either con-
sortium when compared to the unsupplemented diet phases
(p > 0.15, two-tailed Student’s t test).
Applying microbial RNA sequencing (RNA-seq) to fecal sam-
ples collected at the same time points as those used for the
COPRO-seq analysis, we confirmed significantly greater overall
levels of community BSH expression in the BSHhi compared to
the BSHlo consortium’s meta-transcriptome (145-fold; p =
0.006, two-tailed Student’s t test). However, turmeric did not
result in significant changes in the levels of BSH transcripts
in the fecal meta-transcriptomes of BSHlo and BSHhi animals
(p > 0.05, two-tailed Student’s t test). Enterococcus faecalis
(isolate ID hG2) was the only member of the BSHlo consortium
that expressed BSH, albeit at low levels (thus explaining the
presence of fecal unconjugated bile acids in these animals; Fig-
ure 5C). In the BSHhi consortium, the principal contributors of
BSH transcripts to the community meta-transcriptome were
three Bifidobacteria (isolate IDs hB1, hB8, and hF8), which
together accounted for 76% ± 1% (mean ± SEM) of these tran-
scripts. In mice colonized with the BSHlo consortium, turmeric
resulted in significant reductions in expression of two transcripts
in the meta-transcriptome assigned to the KEGG ‘‘dioxin degra-
dation pathway’’ (5.7-fold; p = 0.004, two-tailed Student’s t test):
salicylate 1-monooxygenase (EC 1.14.13.1, a oxidoreductase
that produces catechol) and 4-oxalocrotonate tautomerase
(EC 5.3.2.6; part of a metabolic pathway that generates tricar-
boxylic acid cycle intermediates). In mice colonized with the
BSHhi consortium, no KEGG pathways were significantly differ-
entially expressed as a function of turmeric consumption.
Together, these results suggest that turmeric enhances the
discordance in motility phenotypes between BSHlo and BSHhi
mice not by changing expression of bacterial BSH genes but
rather through its cholekinetic effect, thereby providing conju-
gated bile acids to the two consortia with markedly different
BSH gene content and deconjugation capacities.
Effects of Turmeric on Host Gene Expression
To assess the effects of turmeric on host gene expression, we
focused on the BSHlo consortium because, in the previous
experiment, it transmitted a turmeric-responsive transit time
phenotype. BSHlo mice were monotonously fed either the un-
supplemented or turmeric-supplemented Bangladeshi diet for
10 days. The capacity of turmeric to significantly slow motility
was replicated in this new, single-diet-phase experiment (p =
0.003, one-tailed Student’s t test comparing transit times be-
tween the two diet-treatment groups; Figure 5D). RNA-seq data-
sets were generated from the liver and terminal ileum, essential
components of the enterohepatic circulation. Differentially ex-
pressed genes were identified using the exact negative binomial
test. Genes that satisfied our criteria for significant differences in
expression (after correcting for multiple comparisons) are listed
in Table S8. Transcriptional data generated from the livers of
mice from the 10-day-long monotonous-diet experiment indi-
cated that turmeric consumption was followed by a homeostatic
response designed to maintain bile acid pool size at constant
levels: i.e., consistent with the increased fecal bile acid levels
elicited by turmeric consumption, Cyp7a1 (cholesterol 7a-hy-
droxylase) expression was 3.3-fold lower (p = 0.00002).
Cyp7A1 converts cholesterol into 7a-hydroxycholesterol in the
rate-limiting first step of hepatic bile acid synthesis, a step sub-
ject to feedback inhibition by increased bile acid concentrations.
In the terminal ileum, a total of 96 genes exhibited significant
differential expression in the face of turmeric consumption (Table
S8A), including greater expression of multiple genes involved in
gut mucosal immune/barrier function: Retnlb (resistin-like mole-
cule b, with 410-fold higher expression), Siglec5 (sialic acid
binding Ig-like lectin 5, an eosinophil marker), Fut2 (a-1,2-fuco-
syltransferase; a null allele of this gene in humans confers non-
secretor status and is associated with Crohn’s disease [Tong
et al., 2014], while Fut2 deficiency in mice enhances susceptibil-
ity to infection with eukaryotic and bacterial pathogens [Goto
et al., 2014; Hurd and Domino, 2004]),Nfil3 (nuclear factor, inter-
leukin 3, a transcription factor that directs development of innate
lymphoid cells [ILCs]; Geiger et al., 2014; Klose et al., 2014),
Tnfrsf21 (tumor necrosis factor receptor superfamily member
21, involved in T helper cell function), and Irf2 (interferon regula-
tory factor 2). Retnlb is expressed by intestinal goblet cells and
enterocytes (Hogan et al., 2006) and appears to have various
effects on immunity, including maintenance of mucosal barrier
function (Hogan et al., 2006), macrophage activation to produce
tumor necrosis factor a (TNF-a) (McVay et al., 2006; Steinbrecher
et al., 2011), and protection from gut helminthic infections (e.g.,
by inhibiting migration of worms; Artis et al., 2004; Herbert et al.,
2009). Eosinophils, which, as noted above, express Siglec5,
contribute to protective immunity against parasites (Knott
et al., 2007). Nfil3 expression is linked to ILC accumulation;
group 2 ILCs have been implicated in development of protective
immunity to parasites (Oliphant et al., 2014), while group 3 ILCs
promote Fut2 expression and mediate resistance to bacterial
pathogens such as Salmonella (Goto et al., 2014). Turmeric’s
ability to modulate the distal ileal transcriptome is interesting in
light of the South Asian Ayurvedic tradition of using crushed
turmeric as an anti-helminthic (Handral et al., 2013; Nadkarni
and Nadkarni, 1976). The burden of parasitic infection in this
population is great (Roy et al., 2011); our findings offer one
potential biological insight about why turmeric came to be ubiq-
uitously represented in Bangladeshi cuisine. Though it is unclear
whether these findings relate to our observed motility pheno-
types, they may be of anthropologic significance.
Interplay of the Microbiota, Bile Acids, and the ENS
To assess the degree to which the effect of turmeric on motility
was dependent upon ENS-based signaling (Alemi et al., 2013),
we turned tomice heterozygous for a null allele of theRet receptor
(Tsuzuki et al., 1995). Ret,which encodes a transmembrane pro-
tein that bindsglial cell-derivedneurotrophic factor family ligands,
is the genemost commonly implicated in Hirschsprung’s disease
(Edery et al., 1994; Romeo et al., 1994), a developmental disorder
associated with absent peristalsis in the distal colon. Heuckerothand colleagues have reported that Ret+/ mice exhibit >90% re-
ductions in longitudinal and circular gut muscle contractility and
70%–95% reductions in the release of two neurotransmitters
(substanceP andVIP) compared toRet+/+ animals despite having
equivalent numbers of enteric neurons (Gianino et al., 2003). We
found that conventionally raised wild-type (Ret+/+) mice have
significantly lower transit times (faster motility) than their conven-
tionally raised heterozygous (Ret+/) littermates (p = 0.05, one-
tailed Student’s t test; as shown in Table S2F).
We re-derived C57BL/6 Ret+/ mice as germ-free and colo-
nized the heterozygotes and their wild-type littermates with
either the seven-member BSHlo or seven-member BSHhi con-
sortium. Animals were subjected to a three-phase diet oscillation
as in the experiments described above (unsupplemented ➡
turmeric-supplemented ➡ unsupplemented Bangladeshi diet;
10 days/phase). We hypothesized that if enteric neurons were
key mediators of the observed phenotypes, then the difference
in transit times seen between wild-type mice colonized with
the two different seven-member consortia (Figure 5B) might be
mitigated in Ret+/ animals. Indeed, in contrast to wild-type
mice, transit times were not significantly different between
Ret+/ mice harboring the two different consortia (Table S2D)
despite the same pattern of differences in fecal bile acids con-
centrations documented by UPLC-MS in wild-type mice:
Ret+/ mice colonized with the BSHlo consortium had signifi-
cantly lower fecal concentrations of unconjugated bile acids
compared to Ret+/ mice colonized with the BSHhi consortium
in the setting of turmeric consumption (p = 0.009, one-tailed Stu-
dent’s t test). As in wild-typemice, COPRO-seq analysis showed
that turmeric consumption had no significant effects on the
abundances of any of the bacterial strains in the Ret+/ mice.
Notably, a significant difference in transit times between Ret+/
and wild-type mice was only seen when animals were colonized
with the BSHhi bacterial consortium (diet phase 1: p = 0.009,
phase 2: p = 0.02, phase 3: p = 0.09, one-tailed Student’s
t test; p > 0.05 in all analogous comparisons of Ret+/ versus
wild-typemice colonizedwith the BSHlo consortium). Thus, while
turmeric consumption has a cholekinetic effect in both wild-type
and Ret+/ mice, the transit time phenotype it produces in wild-
type mice is mediated by gut microbial bile acid metabolism and
a functionally intact ENS.
DISCUSSION
Intestinal motility is a key physiologic parameter impacting nutri-
tional status and gut health. The travel-associated diet changes
that we model here are increasingly relevant to our daily lives
during this period of rapid globalization, in which a day spent
entirely in one’s hometown may nonetheless consist of con-
sumption of foods representing several of the world’s cultures.
A gnotobiotic mouse model of global travel could also incorpo-
rate additional factors that impact the gut microbiota, such as
disruption of circadian rhythm (Thaiss et al., 2014) or the order
in which different diets are experienced. Using gnotobiotic
mice colonizedwithmicrobiota obtained from healthy individuals
representing different geographic and cultural traditions and
diets representative of those consumed by these donors, we
were able to dissect factors that interact to define a motilityCell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc. 103
phenotype. These diet-microbiota-metabolic interactions were
resolved in the context of Bangladeshi microbiota through a
multi-pronged strategy that involved (1) manipulating the dietary
representation of a single culturally relevant spice, turmeric;
(2) selecting members of a clonally arrayed culture collection
generated from a Bangladeshi donor’s microbiota, based on
whether or not they were able to support BSH-mediated bile
acid deconjugation; and (3) colonizing germ-free mice with or
without a mutation in Ret, a key regulator of ENS function, with
a BSHhi or BSHlo consortium.
The simulation of global-travel-associated short-term diet
shifts revealed that (1) diet-discriminatory bacterial strains
were represented across microbiota from individuals raised in
environments that are geographically and culturally distinct
and (2) correlations between individual bacterial species abun-
dances and transit times are largely diet dependent, e.g., a given
bacterial strain can have contrasting correlations with transit
times depending upon the diet context. These findings suggest
that future use of bacterial strains derived from the human gut
as probiotic agents for motility disorders will require thoughtful
consideration of an individual’s dietary practices and/or adjunct
dietary recommendations. Reciprocally, our preclinical data
suggest that dietary treatments for motility disorders need to
be calibrated based on structural and functional features of an
individual’s microbiota. In this respect, we find that unconju-
gated bile acids resulting from bacterial metabolism are consis-
tently correlated with faster transit times across different diets
and microbiota. In patients with irritable bowel syndrome, a
limited number of clinical trials have suggested that a subset of
patients respond to oral administration of the unconjugated
bile acid chenodeoxycholate with accelerated transit times
(Odunsi-Shiyanbade et al., 2010; Rao et al., 2010), consistent
with our observations. Our results point to fecal BSH activity
as a functional microbiota parameter that could be useful for cat-
egorizing individuals with motility disorders, allowing correlation
analyses to be performed between the levels of its conjugated
substrates and/or its various unconjugated bile acid products
and transit time. If significantly correlated within a population,
this metabolic activity could be used as a target or biomarker
in clinical studies testing the effects, both short- and long-
term, of various therapeutic interventions.
The imperfect recovery of transit times following consumption
of travel diets, initially noted in the context of the six-phase and
three-phase travel experiments, was also seen in our experi-
ments involving sequential presentation of an unsupplemented,
turmeric-supplemented, and unsupplemented Bangladeshi diet.
Across ecosystems, history (i.e., order and temporal features of
perturbations) is well known to impact community structure and
function (Chase, 2003; Fukami and Morin, 2003; Pagaling et al.,
2014). In this context, turmeric may influence alternative stable
states (Staver et al., 2011) of the gut microbiota and ENS.
Despite our practice of changing bedding between diet phases
to limit carryover of ingredients, turmeric may have long-lived
effects on host physiology. A sustained increase in total bile
acid pool size evoked by turmeric’s cholekinetic effects seems
an unlikely explanation for these observations, as bile acid con-
centrations in the final diet phase returned to pre-turmeric levels
(Figure 5C). Follow-up experiments examining the duration of104 Cell 163, 95–107, September 24, 2015 ª2015 Elsevier Inc.turmeric’s effects on the transcriptome of purified enteric neu-
rons (including the TGR5 bile acid receptor; Alemi et al., 2013)
in combination with analyses of the microbiota and its metabolic
features, localization of motility effects (i.e., gastric, small intes-
tinal, and/or colonic), and production of neuroactive compounds
such as serotonin by enteroendocrine cells (Yano et al., 2015)
could reveal and help characterize this postulated turmeric-
induced alternative stable state.
Other dietary ingredients (e.g., polysaccharides; Kashyap
et al., 2013) and products of bacterial metabolism (e.g., butyrate;
Soret et al., 2010) have been previously described to impact
motility in mouse models. Populations experiencing shifting cul-
tural/culinary traditions through travel, immigration, or emigration
are susceptible to marked changes in their gut microbiota, both
structural and functional, which may have downstream health
consequences. In principle, our approach could be used to iden-
tify and characterize the biological activities andmicrobiota inter-
actions of dietary components characteristic of dietary/cultural
traditions establishedover centuries but nowvulnerable todimin-
ished use due toWesternization. Their exclusion frommodern di-
ets may represent a loss of key food ingredients that could be
used topromote health in contemporary societies. These ingredi-
ents may also serve as valuable tools for identifying and charac-
terizingmechanismsbywhich food and themicrobiota interact to
affect various features of our physiology.
EXPERIMENTAL PROCEDURES
Measurement of Gastrointestinal Transit Times Using Non-
absorbable Red Carmine Dye
Carmine red (Sigma-Aldrich) was prepared as a 6% (w/v) solution in 0.5%
methylcellulose (Sigma-Aldrich) and autoclaved prior to import into gnotobi-
otic isolators. Mice were maintained on a strict 12-hr light cycle (lights on
between 06:00 and 18:00) and gavaged with 150 ml of the carmine solution be-
tween 08:00 and 08:30 local time. Animals were not fasted beforehand. Feces
were collected every 30 min (up to 8 hr from time of gavage) and streaked
across a sterile white napkin to assay for the presence of the red carmine
dye. The time from gavage to initial appearance of carmine in the feces was
recorded as the total intestinal transit time for that animal.
Generating a Clonally Arrayed Culture Collection of Anaerobic
Bacterial Strains from the Fecal Microbiota of a Healthy 24-Month-
Old Bangladeshi Child
Aclonally arrayed culture collectionwas generated usingmethodsdescribed in
an earlier publication (Goodman et al., 2011). A given well of the 96-well plate
used to archive the collection contained a monoculture of a single isolate.
Each isolate’s genomewassequencedusing an IlluminaMiSeqorHiSeq instru-
ment (250-nt and 101-nt paired end reads, respectively; 53- ± 4.8-fold (mean ±
SEM) genome coverage). Genomes were assembled using MIRA (Chevreux
et al., 1999) (N50 contig length: 23,253 ± 2,669 bp; range, 735–112,622 bp).
Assemblies were annotated using Prokka (version 1.10) (Seemann, 2014). Pre-
dicted genes were mapped to KEGG pathways by querying the KEGG refer-
ence database (release 72.1) and assigning their protein products to KEGG
Ortholog (KO) groups (BLAST 2.2.29+, blastp E-value threshold%1010, single
best hit defined by E-value and bit score) (Kanehisa and Goto, 2000; Kanehisa
et al., 2014). Species-level taxonomic identities of bacterial isolates were
definedbySanger capillary sequencing of full-length 16S rRNAgeneamplicons
generated using the universal 8F and 1391R PCR primers, with classifications
performed using the Ribosomal Database Project (RDP) version 2.4 classifier
(Ridaura et al., 2013). Strain-level taxonomic classifications were subsequently
determined based on a minimum 96% overall genome sequence identity
(calculated by the software package NUCmer; Kurtz et al., 2004) between iso-
lates bearing the same 16S rRNA-based taxonomy. A total of 53 unique strains
were identified using this 96% identity cutoff threshold and grown in modified
gutmicrobiotamedium (mGMM) containing ingredients described in a previous
publication (Goodman et al., 2011) but without short-chain fatty acid supple-
mentation. Strains were stored at 80C in 15% glycerol (v/v) in reduced
PBS until used for gavage of germ-free mice.
In Vitro Assays for Bile Acid Deconjugation
We screened each of the 91 isolates, comprising 53 strains, in the clonally ar-
rayed culture collection for their capacity to deconjugate bile acids. The two
predominant primary bile acids in mice, taurocholic acid (TCA; Sigma-Aldrich)
and tauro-beta-muricholic acid (TbMCA; Santa Cruz Biotechnology), were dis-
solved in water at concentrations of 100 mg/ml and 10 mg/ml, respectively.
Each isolate was first incubated in 1 ml mGMM containing 100 mM TCA for
48 hr in an anaerobic Coy chamber (75% N2, 20% CO2, and 5% H2) with
growth monitored based on optical densities at 600 nm (OD600). Cells were
then pelleted by centrifugation (17,900 3 g for 7 min at 4C), and the resulting
supernatant was subjected to UPLC-MS (see Supplemental Experimental Pro-
cedures) to assess levels (peak intensities) of unconjugated and conjugated
bile acids (cholic acid and TCA, respectively). For the vast majority of isolates,
bile acid profiles at 48 hr were either all conjugated or unconjugated. Growth of
bacterial isolates was simultaneously assessed by measuring OD600 to ensure
that a lack of deconjugation was not simply a reflection of a lack of bacterial
viability. If no deconjugation was observed, we performed a secondary screen
where isolates were incubated in 1 ml mGMM containing 100 mM TbMCA for
48 hr in an anaerobic chamber, followed byUPLC-MS quantitation of the levels
of unconjugated (beta-muricholic acid) and conjugated (TbMCA) bile acids.
Bacterial isolates that did not deconjugate either bile acid in vitro were consid-
ered as eligible for the BSHlo consortium. See Supplemental Experimental Pro-
cedures for additional protocols.
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